Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03512756
Title A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tyme, Inc
Indications

pancreatic adenocarcinoma

Therapies

Methoxsalen + Phenytoin + Sirolimus + SM88

Gemcitabine

Fluorouracil

Capecitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.